logo
logo

Sequence Based, Ai-Driven Drug Discovery Company, Deargen Raises Us$17 Million In Seriesb Financing Round To Accelerate In-House Pipeline

Sequence Based, Ai-Driven Drug Discovery Company, Deargen Raises Us$17 Million In Seriesb Financing Round To Accelerate In-House Pipeline

02/24/22, 2:00 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/KR.svgseoul
Money raised
$17 million
Deargen Inc., an AI-powered drug discovery and development company, announced on the 24th that it has raised US$17million in a series B financing round. This will be used to accelerate in-house pipeline by establishing a drug development research institute.

Company Info

Company
Deargen
Location
seoul, seoul, south korea
Additional Info
The company plans to establish an AI-integrated new drug development system that supports not only the initial stages of a study, such as from target discovery to substance design but also synthesis and drug development.